PRRT2 and B-cell chronic lymphocytic leukemia: Our previous studies of PKCβII in the malignant cells of B lymphoproliferative disorders have shown that overexpression of this PKC isoform is a phenotypic feature of chronic lymphocytic leukaemia (CLL) cells11.